Sign In
Pharma
Wockhardt Eyes $7 Bn Mkt For Its Antibiotic Zaynich
Markets
Pharma Stocks Sink
Q1 Results
Wockhardt shareholders turn down proposal to raise Rs1,600cr
Wockhardt’s former executive banned for insider trading
